MedTrace Logo

Transcranial Direct Current Stimulation Therapy for Major Depression

NCT03632434 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2024-08-01

Study results available
· View outcomes & findings →

Summary

Depression is a prevalent and debilitating disorder. The most common treatments are antidepressant medications and talking therapies. However, for many individuals, these are not their treatment of choice. Furthermore, even following a full course of treatment with an antidepressant or talking therapy, over one third of patients continue to be unwell.

The novel brain stimulation treatment, transcranial direct current stimulation (tDCS), is a potential first-line treatment for major depression. The present research question is whether tDCS can be provided as a home-based treatment for major depression for adults with major depression.

Conditions

Interventions

DEVICE

transcranial direct current stimulation

tDCS generates a small electric current which modulates how easy it is for active brain cells to discharge. The device is a neoprene cap worn over the head, and in the cap there are two electrodes, which are small metal discs, where the current comes from.

Sponsors & Collaborators

  • Rosetrees Trust

    collaborator OTHER

  • King's College London

    collaborator OTHER

  • University College, London

    collaborator OTHER

  • University of Oxford

    collaborator OTHER

  • University of East London

    lead OTHER

Principal Investigators

  • Cynthia Fu, MD PhD · University of East London

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-14
Primary Completion
2021-11-26
Completion
2021-11-26

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03632434 on ClinicalTrials.gov